Press Releases

SAN MATEO, Calif., Dec. 2, 2019 /PRNewswire/ -- The Gastric Cancer Foundation (GCF) celebrated its 10th Anniversary during its Cause For Hope fundraiser on Saturday, November 16, 2019 at the Peninsula Golf and Country Club in San Mateo, California. With 200 supporters attending, more than

NEW YORK, Dec. 2, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Baxter International Inc. (NYSE: BAX) between February 21, 2019 and October 23, 2019, inclusive (the "Class Period"). The laws

STAINES-UPON-THAMES, United Kingdom, Dec. 2, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that

ST. LOUIS, Dec. 2, 2019 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("Centene") announced today the extension of the expiration date of the offers to exchange (the "Exchange Offers") notes (the "WellCare Notes") issued by WellCare Health Plans, Inc. (NYSE:WCG) ("WellCare") for up to $1,950,000,000 aggregate principal amount of new notes t

CHICAGO, Dec. 2, 2019 /PRNewswire/ -- It's been four years since medical cannabis became legal in Illinois, yet an alarmingly low percentage of physicians support patients who wish to incorporate cannabis into their healthcare. Rahul Khare, MD, president and founder of Innovative Wellness, believes it's

LOS ANGELES, Dec. 2, 2019 /PRNewswire/ -- This GivingTuesday, Movember, the leading men's health charity, is challenging participants to do a dare for donations to raise those last-minute, much-needed funds. From half-shaven moustaches to dying their upper lip fur, Movember is asking Mo Bros and Mo Sisters to take it one step further t

PALO ALTO, Calif., Dec. 2, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that it has commenced an underwritten public offering of $250,000,000 of shares of its common stock. In connectio

INDIANAPOLIS, Dec. 2, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December 4, 2019. Daniel Skovronsky, M.D., Ph.D., Lilly's Chief Scientific Officer and President of Lilly Research Laboratories, will p

DUBLIN, Dec. 2, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has completed the acquisition of the branded over-the-counter (OTC) rights to Prevacid®24HR. 

NERLYNX® (neratinib) now approved in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy NERLYNX is the first therapy in the Specialised Therapeutics' portfolio approved in SE Asia Five-year follow up data show NERLYNX reduces risk of invas